171 related articles for article (PubMed ID: 38280005)
21. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
22. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
Chen S; Zeng J; Huang L; Peng Y; Yan Z; Zhang A; Zhao X; Li J; Zhou Z; Wang S; Jing S; Hu M; Li Y; Wang D; Wang W; Yu H; Miao J; Li J; Deng Y; Li Y; Liu T; Xu D
J Transl Med; 2022 May; 20(1):228. PubMed ID: 35568866
[TBL] [Abstract][Full Text] [Related]
23. Single-cell and spatial transcriptomics reveal metastasis mechanism and microenvironment remodeling of lymph node in osteosarcoma.
Liu Y; He M; Tang H; Xie T; Lin Y; Liu S; Liang J; Li F; Luo K; Yang M; Teng H; Luo X; He J; Liao S; Huang Q; Feng W; Zhan X; Wei Q
BMC Med; 2024 May; 22(1):200. PubMed ID: 38755647
[TBL] [Abstract][Full Text] [Related]
24. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
Wang H; Li J; Li X
Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
[TBL] [Abstract][Full Text] [Related]
25. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
[TBL] [Abstract][Full Text] [Related]
26. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
[TBL] [Abstract][Full Text] [Related]
27. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma.
Shi D; Mu S; Pu F; Liu J; Zhong B; Hu B; Ni N; Wang H; Luu HH; Haydon RC; Shen L; Zhang Z; He TC; Shao Z
Mol Oncol; 2022 Jun; 16(11):2174-2194. PubMed ID: 34894177
[TBL] [Abstract][Full Text] [Related]
29. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
30. Unraveling the Heterogeneity of CD8+ T-Cell Subsets in Liver Cirrhosis: Implications for Disease Progression.
Zheng K; Dai L; Zhang S; Zhao Y; Li W; Gao Y; Mang Y; Jiao L; Tang Y; Ran J
Gut Liver; 2024 Apr; ():. PubMed ID: 38623058
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
32. T-cell exhaustion: A potential target biomarker of the tumour microenvironment affecting oesophageal adenocarcinoma.
Peng S; Han X; Geng W; Zhao L
J Gene Med; 2023 Jul; 25(7):e3496. PubMed ID: 36879295
[TBL] [Abstract][Full Text] [Related]
33. Identification of T-cell exhaustion-related gene signature for predicting prognosis in glioblastoma multiforme.
Liu YH; Jin HQ; Liu HP
J Cell Mol Med; 2023 Nov; 27(22):3503-3513. PubMed ID: 37635346
[TBL] [Abstract][Full Text] [Related]
34. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
36. A systematic and comprehensive analysis of T cell exhaustion related to therapy in lung adenocarcinoma tumor microenvironment.
Hu P; Ma J; Chen J
Front Pharmacol; 2023; 14():1126916. PubMed ID: 36814485
[No Abstract] [Full Text] [Related]
37. Construction and validation of a novel NAD
Yu R; Lu G; Cheng B; Li J; Jiang Q; Lan X
J Orthop Res; 2024 May; 42(5):1086-1103. PubMed ID: 38047487
[TBL] [Abstract][Full Text] [Related]
38. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
[TBL] [Abstract][Full Text] [Related]
39. Studying the mechanism underlying lipid metabolism in osteosarcoma based on transcriptomic RNA sequencing and single-cell data.
Li Z; Jin C; Lu X; Zhang Y; Zhang Y; Wen J; Liu Y; Liu X; Li J
J Gene Med; 2023 Jun; 25(6):e3491. PubMed ID: 36847293
[TBL] [Abstract][Full Text] [Related]
40. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
Front Immunol; 2022; 13():992266. PubMed ID: 36405691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]